上市公司 Propanc Biopharma 计划收购 1 亿美元以太坊
ChainCatcher 消息，生物制药公司 Propanc Biopharma (纳斯达克股票代码: PPCB) 宣布计划在未来 12 个月内收购价值 1 亿美元的以太坊
该公司表示，此举将增强其在加密货币投资、药物开发和资产收购等多方面的企业战略
风险提示 风险提示
关联标签
关联标签
扫码下载
BTC $77,966.58 -1.06%
ETH $2,332.32 -2.94%
BNB $636.32 -1.89%
XRP $1.42 -2.18%
SOL $86.01 -3.12%
TRX $0.3281 -0.38%
DOGE $0.0965 -1.27%
ADA $0.2481 -2.66%
BCH $458.40 -1.08%
LINK $9.30 -2.01%
HYPE $41.50 +1.17%
AAVE $93.15 -1.12%
SUI $0.9423 -2.94%
XLM $0.1773 -1.48%
ZEC $330.07 +2.57% BTC $77,966.58 -1.06% ETH $2,332.32 -2.94% BNB $636.32 -1.89% XRP $1.42 -2.18% SOL $86.01 -3.12% TRX $0.3281 -0.38% DOGE $0.0965 -1.27% ADA $0.2481 -2.66% BCH $458.40 -1.08% LINK $9.30 -2.01% HYPE $41.50 +1.17% AAVE $93.15 -1.12% SUI $0.9423 -2.94% XLM $0.1773 -1.48% ZEC $330.07 +2.57%
风险提示 风险提示
ChainCatcher 与创新者共建Web3世界
